Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKesson
Dow
McKinsey
Moodys
Harvard Business School
Baxter

Last Updated: May 29, 2023

Dr Reddys Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for DR REDDYS, and what generic and branded alternatives to DR REDDYS drugs are available?

DR REDDYS has two hundred and eighty-three approved drugs.

There are twenty-four tentative approvals on DR REDDYS drugs.

Summary for Dr Reddys
US Patents:0
Tradenames:223
Ingredients:211
NDAs:283

Drugs and US Patents for Dr Reddys

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd OLANZAPINE olanzapine TABLET;ORAL 076255-003 Apr 23, 2012 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Dr Reddys Labs Sa BIORPHEN phenylephrine hydrochloride SOLUTION;INTRAVENOUS 212909-001 Oct 21, 2019 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Dr Reddys Labs Ltd CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 075593-001 Jun 9, 2004 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Dr Reddys COLESEVELAM HYDROCHLORIDE colesevelam hydrochloride TABLET;ORAL 210889-001 Oct 5, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Dr Reddys PROPOFOL propofol INJECTABLE;INJECTION 205067-001 Nov 15, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Dr Reddys NEOSTIGMINE METHYLSULFATE neostigmine methylsulfate SOLUTION;INTRAVENOUS 209135-001 Jul 10, 2018 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Dr Reddys

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-004 Nov 12, 1999 5,834,011 ⤷  Try a Trial
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-004 Nov 12, 1999 4,597,961 ⤷  Try a Trial
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-005 Nov 12, 1999 5,834,011 ⤷  Try a Trial
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-006 Nov 12, 1999 5,834,011 ⤷  Try a Trial
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-006 Nov 12, 1999 5,016,652 ⤷  Try a Trial
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-006 Nov 12, 1999 4,597,961 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for DR REDDYS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe for Injection 100 mcg/vial and 500 mcg/vial ➤ Subscribe 2015-04-14
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
➤ Subscribe for Injection 200 mcg/vial ➤ Subscribe 2015-05-01
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Colorcon
Baxter
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.